Download Alternative RNA splicing in latently infected T cells generates

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Eukaryotic transcription wikipedia , lookup

Silencer (genetics) wikipedia , lookup

Secreted frizzled-related protein 1 wikipedia , lookup

RNA silencing wikipedia , lookup

RNA polymerase II holoenzyme wikipedia , lookup

Alternative splicing wikipedia , lookup

Gene regulatory network wikipedia , lookup

Non-coding RNA wikipedia , lookup

Endogenous retrovirus wikipedia , lookup

Cell culture wikipedia , lookup

Gene expression wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Epitranscriptome wikipedia , lookup

Transcriptional regulation wikipedia , lookup

RNA-Seq wikipedia , lookup

List of types of proteins wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Transcript
Alternative RNA splicing in latently infected
T cells generates chimeric cellular:HIV
mRNAs with the potential to generate Tat
and reactivate infection
Con Sonza, Talia Mota, Jonathan Jacobson, Michelle Lee,
Giovana Bernardi, Jane Howard, Damian Purcell
The University of Melbourne, Department of Microbiology and Immunology
at the Peter Doherty Institute
The current need for Latency targeting therapy:
CD4+ T cell
(weeks)
HIV-1 infected
cell
Interruption
of cART
cART
Early infection
Latency
Rebound - AIDS
cART is able to suppress plasma viraemia below detectable levels, however the reservoir of
latently infected cells persists. Interruption or discontinuation of cART is followed by
rebound of viraemia and progression to AIDS.
HIV gene expression during latency in resting memory T-cells
HIV specific host
microRNA
Cellular factors
-Limited
transcriptional
activators
Impaired RNA export
from nucleus
Viral factors
-Site of integration (into active gene)
-Transcriptional interference*
-Low acetylation
-High methylation
Chromatin
remodelling
(epigenetics)
RNA
transcription
RNA splicing
m7G-capping
Tat
microRNA
expression
Cell-activation /
senescence
Mechanisms that establish and/or maintain
latency: Transcriptional Interference
Adapted from Siliciano RF, Greene WC. 2011
CENTRAL HYPOTHESIS: cART selects HIV provirus integrated into the introns of
transcriptionally active genes where read-through transcription includes HIV RNA
A7
Cap-dependent Tat vs IRES-Tat
Transfection of TZM-bl reporter cells
pcDNA3.150
100
150
200
250
300
350
400
450
500
550
600
100
200
300
400
500
600
700
800
900
1000
1100
1200
1300
1400
1500
Relative Luciferase Activity
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
Cap-Tat (ng)
IRES-Tat (ng)
Michelle Lee, 2014
Read-through transcription splices HIV tat exon2 onto cell
NT5C3 mRNA in the ACH-2 cell line model of HIV-1 latency
PCR primers
Ex4
Ex5
D1
2605
2595
- pA
A3
2601
Ex6
D4
Ex7
Ex8
Ex9
- pA
Ex1
introns
Ex2
Ex3
- pA
AUG
ACH2 latent T cell line
2603
2604
32P-probes
Odp2605
HIV-U3
Odp2601
gag-5’
Odp2603
tat exon 2
Odp2604
env/vpu
1 2 3
1 2 3
1 2 3
1 2 3
Ex5
U3
2605
1. Uninfected Jurkat cells
2601
A2 A3
D1
2. Unstimulated ACH2 cells
2604
2603
D4
3. PMA-stimulated ACH2 cells
Jane Howard, 2013
Latently infected J-Lat6.3 cells produce chimeric
cell:tat RNA by read-through transcription and splicing
Michelle Lee, 2013
Functional Tat protein is expressed from spliced cell:tat mRNA using an
Internal Ribosome Entry Site (IRES) underlying the Tat coding sequence
ACH2
J-Lat
25000
Luciferase activity
Luciferase activity
10000
8000
6000
4000
2000
20000
15000
10000
5000
0
A3.01
Unstimulated
PMA stimulated
0
Jurkat
A3.01
Unstimulated
TNF stimulated
Transduction of the latently infected ACH2 and J-Lat6.3 cell lines
with a Tat responsive LTR-Luciferase reporter pseudovirus
Pseudovirus (after RT):
U3
R
U5
∆Gag
2 5
∆Env
Nef
Fluc
Nef
U3
R
U5
Giovana Bernardi, 2013
Latently-infected primary CD4 T cells express
chimeric cellular:tat mRNAs Southern blot
Donor 1
Donor 2
probed with
tat exon 2 probe
Uninfected
control
Alu-tat PCRs of
cDNA from
CCL19-treated,
memory CD4 T
cells infected
with NL4.3
Donor 2
- :RT
Donor 1
+
Uninfected
control
MW
Nested tat PCR
tat
exon 2
MW
MW
+
+
+
+
+
-
Cloned, sequenced
+
DNAse
RT
Talia Mota
Distribution of integration sites in five patients.
A total of 2410 integration sites were obtained from PBMCs or negatively selected
CD4+ cells from the five patients.
F Maldarelli et al. Science 2014;345:179-183
Detection of chimeric cell:tat RNA in primary
resting CD4 T cell latency model
STAT5B
Exon 5
DDX6
Exon 8
Exon 2
HORMAD2
Exon 2
Exon 9
Exon 5
Exon
- pA
- pA
PCR of cDNA from CCL19 chemokine-induced resting CD4 T cells infected with HIV-1NL4.3
(Saleh et al, Blood, 2007) using various cellular gene exon forward primers and
tat exon2 reverse primer
A3
D1
D4
Exon
Read-through transcription and splicing generate chimeric
cell:tat RNAs in latently infected primary CD4 T cells
Forward Primers
STAT5B
1 2 3 4 5
HORMAD2
1 2 3 4 5
- pA
- pA
Reverse primers
1. LTR-U3
2. gag
3. tat exon 2-ls
4. tat exon 2-cs
5. SD1/SA3
A3
Exon
Exon
D1
D4
Conclusions
• During read-through transcription in latently infected T cell
lines and primary resting CD4 T cells, chimeric cell:tat RNAs are
generated by the usual cellular mechanisms of alternative RNA
splicing
• An IRES-like element in tat leads to translation of this mRNA in
a cap-independent manner and expression of functional Tat
protein (POSTER THPE006: G. Khoury)
• Because of the central role of Tat in the establishment and
maintenance of latency, factors affecting transcription, splicing,
cytoplasmic localization or translation of Tat from chimeric
RNAs will impact on HIV latency
• Such factors could be targeted to develop novel, more specific,
strategies to assist in the activation and clearance of the latent
reservoir or prevent viral rebound upon cessation of cART
(POSTER THPE016: J. Jacobson)
Acknowledgments
University of Melbourne
Damian Purcell
Talia Mota
Jonathan Jacobson
Michelle Lee
Giovana Bernardi
Jane Howard
Leanne Ng
Alfred Hospital /
Burnet institute /
Monash University
Sharon Lewin
Paul Cameron
Fiona Whiteman
Suha Saleh
Vanessa Evans
NHMRC and ACH2
for funding.